V
Vitestro
Autonomous robotic phlebotomy for diagnostic blood collection (Aletta ARPD)
About Vitestro
Vitestro is a Utrecht medical-robotics company that develops Aletta, a CE-marked Autonomous Robotic Phlebotomy Device (ARPD) combining multimodal imaging, robotics and AI to identify veins, guide needle insertion and collect diagnostic blood samples for high-volume outpatient settings. Founded by CEO Toon Overbeeke and team, Vitestro aims to standardize quality, ease staffing pressure and improve patient experience while advancing a U.S. FDA De Novo pathway alongside European clinical deployments. In March 2026 Vitestro closed an oversubscribed $70 million Series B with new strategic investors Labcorp Venture Fund, Mayo Clinic and Sutter Health, plus InterVest, MGFO, PGGM, Puma Venture Capital and ROM Utrecht, and returning Invest-NL, EIC Fund, Fred Moll, NYBC Ventures and Sonder Capital, to advance the next-generation Aletta platform, manufacturing and commercial readiness. Sources: PR Newswire 10 Mar 2026.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Utrecht, Netherlands
- Employees
- 132
- Open positions
- 11
- Dealroom signal
- 86.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Testing, Patient Care, Core AI, EIC, Medical Robots, Tech for Hospitals and Clinics
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Autonomous & Sensor Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2026 | $70M | $280M | LabCorp · Mayo Clinic · InterVest · Invest-NL | ↗ |
| SERIES AOther financing | Apr 2024 | $22M | $88M | NYBC Ventures · Sonder Capital · EIC Fund | ↗ |
Growth signals
Latest recorded traffic for Vitestro is 1.9K monthly website visits, down 77.4% over the last three months. Vitestro's team grew 21.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A13 investors entered at this stage
EIC Fund
Sonder Capital
NYBC Ventures
LabCorp
Mayo Clinic
InterVest
Invest-NL
Frederic Moll
Sutter Health
PGGM Investments
ROM Utrecht Region - Regional Development Agency
Puma Venture Capital
MGFO
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vitestro on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vitestro’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.